Event Details

Event Details

Event Details

2022 Multidisciplinary Head And Neck Cancers Symposium

02/24/22 - 02/26/22

Supporting Materials

2022 HNSCC Symposium Poster: Phase 1/2 study of pepinemab in combination with pembrolizumab as first-line treatment of advanced, recurrent or metastatic head and neck cancer (KEYNOTE B84) 1.6 MB

Title

2022 Multidisciplinary Head And Neck Cancers Symposium

Date / Time

02/24/22 - 02/26/22